Fifty patients with acute myocardial infarction were randomly assigned to receive either intracoronary streptokinase or standard (control) therapy within about three hours after the onset of pain. Coronary perfusion was reestablished in 19 of 24 patients receiving streptokinase. Streptokinase alleviated pain (as indicated by differences in subsequent morphine use). The Killip class was significantly improved after therapy with streptokinase, as were changes in radionuclide ejection fraction between Days 1 and 10 in surviving patients (+3.9 vs. -3.0 per cent, P less than 0.01). The echocardiographic wall-motion index also showed greater improvement after streptokinase treatment (P less than 0.01). Streptokinase therapy was associated with rapid evolution of electrocardiographic changes, which were essentially complete within three hours after therapy, but loss of R waves, ST elevation, and development of Q waves in the convalescent period were greater in the control group (P less than 0.01). The time required to reach peak plasma enzyme concentrations was significantly shorter after streptokinase. The incidence of early and late ventricular arrhythmias was not affected by treatment. We conclude that intracoronary streptokinase appears to have a beneficial effect on the early course of acute myocardial infarction.
This article has been cited by other articles:
Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E. Jr, Chavey, W. E. II, Fesmire, F. M., Hochman, J. S., Levin, T. N., Lincoff, A. M., Peterson, E. D., Theroux, P., Wenger, N. K., Wright, R. S., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Halperin, J. L., Hunt, S. A., Krumholz, H. M., Kushner, F. G., Lytle, B. W., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B.
(2007). ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol
50: e1-e157
[Full Text]
Rosenzweig, A.
(2006). Cardiac cell therapy--mixed results from mixed cells.. NEJM
355: 1274-1277
[Full Text]
Kloner, R. A., Rezkalla, S. H.
(2004). Cardiac protection during acute myocardial infarction: Where do we stand in 2004?. J Am Coll Cardiol
44: 276-286
[Abstract][Full Text]
Birnbaum, Y, Drew, B J
(2003). The electrocardiogram in ST elevation acute myocardial infarction: correlation with coronary anatomy and prognosis. Postgrad. Med. J.
79: 490-504
[Abstract][Full Text]
Xing, D., Martins, J. B.
(2001). Myocardial ischemia-reperfusion damage impacts occurrence of ventricular fibrillation in dogs. Am. J. Physiol. Heart Circ. Physiol.
280: H684-H692
[Abstract][Full Text]
Klamann, A, Sarfert, P, Launhardt, V, Schulte, G, Schmiegel, W.H, Nauck, M.A
(2000). Myocardial infarction in diabetic vs non-diabetic subjects. Survival and infarct size following therapy with sulfonylureas (glibenclamide). Eur Heart J
21: 220-229
[Abstract]
Beltrame, J. F., Sasayama, S., Maseri, A.
(1999). Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and caucasian patients. J Am Coll Cardiol
33: 1442-1452
[Abstract][Full Text]
White, H. D., Barbash, G. I., Califf, R. M., Simes, R. J., Granger, C. B., Weaver, W. D., Kleiman, N. S., Aylward, P. E., Gore, J. M., Vahanian, A., Lee, K. L., Ross, A. M., Topol, E. J.
(1996). Age and Outcome With Contemporary Thrombolytic Therapy: Results From the GUSTO-I Trial. Circulation
94: 1826-1833
[Abstract][Full Text]
Kellett, J., Clarke, J.
(1995). Comparison of "Accelerated" Tissue Plasminogen Activator with Streptokinase for Treatment of Suspected Myocardial Infarction. Med Decis Making
15: 297-310
[Abstract]
Kennedy, J. W.
(1995). Optimal Management of Acute Myocardial Infarction Requires Early and Complete Reperfusion. Circulation
91: 1905-1907
[Full Text]
Babalis, D. C., Boutos, G. N., Iliodromitis, E. K., Trovas, A. K., Vorides, E. M.
(1989). Precordial ECG Mapping in Acute Myocardial Infarction (AMI) After Intravenous Infusion of Streptokinase (s). ANGIOLOGY
40: 1040-1047
[Abstract]
Previous
